Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.58
+0.11 (+0.40%)
Official Closing Price
Updated: 7:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
36,986,735
Open
27.60
Bid (Size)
27.60 (100)
Ask (Size)
27.65 (1,000)
Prev. Close
27.47
Today's Range
27.57 - 27.94
52wk Range
20.91 - 27.94
Shares Outstanding
5,606,688,356
Dividend Yield
6.24%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?
↗
February 14, 2026
Eli Lilly continues to pursue smart acquisitions for the long term.
Via
The Motley Fool
Topics
Intellectual Property
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
February 13, 2026
Moderna Inc. (NASDAQ: MRNA) shares jumped 8% in early trading on February 13, 2026, after the biotechnology pioneer reported fourth-quarter 2025 financial results that exceeded Wall Street’s...
Via
MarketMinute
Topics
Earnings
Performance
YTD
+9.5%
+9.5%
1 Month
+6.5%
+6.5%
3 Month
+10.0%
+10.0%
6 Month
+10.0%
+10.0%
1 Year
+8.0%
+8.0%
More News
Read More
Hospitals Stand Tall: Healthcare Sector Becomes Safe Haven Amid "Warsh Shock" and Tech Volatility
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026
↗
February 13, 2026
Via
The Motley Fool
Topics
Intellectual Property
Healthcare’s Renaissance: Sector Outshines Tech as Policy Clarity Sparks Q4 Surge
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
S&P 500 Breaches 7,000 Milestone: AI Megacaps Propel Market to Historic Heights
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance
February 12, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%
February 12, 2026
Via
MarketMinute
Topics
Earnings
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates
February 12, 2026
Via
StockStory
Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors Are Bullish
↗
February 11, 2026
Via
Talk Markets
Is Now the Best Time to Buy Pfizer Stock?
↗
February 11, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish
February 11, 2026
Via
Barchart.com
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
↗
February 11, 2026
Via
The Motley Fool
Moderna (MRNA) Deep Dive: Navigating Regulatory Blows and the Pivot to Oncology
February 11, 2026
Via
Finterra
Topics
Artificial Intelligence
Initial Public Offering
Intellectual Property
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know
↗
February 10, 2026
Via
The Motley Fool
Is 2026 the Year of Dividend Stocks? These 2 Income-Focused ETFs Have Been Soaring Past the S&P 500
↗
February 10, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
CVS Health Navigates a Stormy 2026: Record Revenue Tempered by Medicare Advantage Costs and PBM Turmoil
February 10, 2026
Via
MarketMinute
Topics
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026
February 10, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Fraud
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
World Trade
Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains?
↗
February 10, 2026
Via
The Motley Fool
5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call
February 10, 2026
Via
StockStory
Topics
Artificial Intelligence
Earnings
Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend?
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.58
When was Pfizer last traded?
The last trade of Pfizer was at 02/13/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 154.63B
How many shares of Pfizer are outstanding?
Pfizer has 155B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.